neuroscienceCME Webcast
Encore Date: Monday, April 6, 2009This activity offers CE credit for:
All other clinicians will either receive a CME Attendance Certificate or may choose any of the types of CE credit being offered.
- Physicians (ACCME/AMA PRA Category 1)
- Nurses (CNE)
- Pharmacists (ACPE)
- Psychologists (APA)
- Social Workers (NASW)
- Certified Case Managers (CCMC)
Credit Expiration Date:
Tuesday, February 23, 2010
Faculty
Rakesh Jain, MD, MPH
Director, Adult and Child Psychopharmacology Research
R/D Clinical Research, Inc.
Lake Jackson, TX
Larry Culpepper, MD, MPH
Professor and Chairman
Department of Family Medicine
Boston University School of Medicine
Chief, Division of Family Medicine
Boston Medical Center
Boston, MAStatement of Need
The application of a chronic disease model to the management of depression is lagging behind other therapeutic areas owing to system-, provider-, and patient-related barriers. Yet the incorporation of this model can help to improve fragmented care, address gaps between best care and usual care, improve coordination of care, enhance outcomes, and reduce costs.(1) Critical to this model is the implementation of screening tools and a clear understanding of how to read and evaluate these tools in a primary care practice.(2) Communication between the primary care provider and the psychiatrist is vital in order to streamline care, optimize resources, incorporate the latest guidelines and evidence, and avoid overlap that can result in dangerous medical outcomes and increased costs. The involvement of a multidisciplinary treatment team can provide synchronized and coordinated care. A team of providers including the primary care physician, psychiatrist, pharmacist, psychologist, nurse, and case manager, all sharing a common goal for the patient, can ensure that care is optimized by selecting appropriate medication, supporting medication adherence, managing side effects and efficacy issues, and incorporating behavioral and/or psychotherapeutic interventions into the treatment plan when warranted. Research has shown that this team approach indeed improves treatment adherence and recovery.(3) In this neuroscienceCME webcast, faculty will discuss system-wide barriers to improved recognition and management of depression in primary care, and will review both guidelines and the evidence base for using a team-based approach to improve outcomes.
- Agency for Healthcare Research and Quality. Screening for depression: systematic evidence review number 6. Rockville, MD. Agency for Healthcare Research and Quality; 2002.
- Gilbody S, et al. Educational and organizational interventions to improve the management of depression. JAMA 2003;289:3145-3151.
- Katon W, et al. Rethinking practitioner roles in chronic illness: the specialist primary care physician and the practice nurse. Gen Hosp Psychiatry 2001;23:138-144.
Activity Goal
To identify system-, provider-, and patient-related barriers to coordinated care for patients with depression, and to provide mental healthcare practitioners with strategies drawn from the evidence base and guidelines for developing team-based care to improve outcomes for this patient population.
Learning Objectives
At the end of this CE activity, participants should be able to:
- Improve awareness and response to healthcare systems-related barriers to recognition, screening, and coordinated care for patients with depression.
- Integrate a team care approach into practice in order to facilitate involvement of and communication between clinical stakeholders, patients, and their families.
- Increase utilization of established clinical guidelines for primary care treatment of depression.
Target Audience
Physicians, physician assistants, nurse practitioners, nurses, pharmacists, psychologists, social workers, certified case managers, and other healthcare professionals with an interest in mental health.
Financial Support
CME Outfitters, LLC, gratefully acknowledges an educational grant from Wyeth Pharmaceuticals in support of this CE activity.
Credit Information
CME Credit (Physicians):
CME Outfitters, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. CME Outfitters, LLC, designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Note to Physician Assistants: AAPA accepts Category I credit from AOACCME, Prescribed credit from AAFP, and AMA Category I CME credit for the PRA from organizations accredited by ACCME.CNE Credit (Nurses):
CME Outfitters, LLC, is an approved provider of continuing nursing education by the New York State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
It has been assigned code 6WASUP-PRV-0653. 1.0 contact hours will be awarded upon successful completion.
Note to Nurse Practitioners: The content of this CNE activity pertains to Pharmacology.CEP Credit (Psychologists):
CME Outfitters is approved by the American Psychological Association to sponsor continuing education for psychologists. CME Outfitters maintains responsibility for this program and its content. (1.0 CE credits)
NASW Credit (Social Workers):
This program was approved by the National Association of Social Workers (provider #886407722) for 1 continuing education contact hour.CCMC Credit (Certified Case Managers):
This program has been approved for 1 hour by the Commission for Case Manager Certification (CCMC).CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hours (0.1 CEUs)
Universal Program Number: 376-000-09-004-H01-P
Activity Type: knowledge-based
Post-tests, credit request forms, and activity evaluations can be completed online at www.neuroscienceCME.com (click on the Testing/Certification link under the Activities tab - requires free account activation), and participants can print their certificate or statement of credit immediately (70% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.neuroscienceCME.com/technical.asp.Rakesh Jain, MD, MPH
Rakesh Jain, MD, MPH, is Director of Psychiatric Drug Research for the R/D Clinical Research Center at Lake Jackson, Texas.
Dr. Jain attended medical school at the University of Calcutta in India. He then attended graduate school at the University of Texas School of Public Health in Houston, where he was awarded a National Institute/Center for Disease Control Competitive Traineeship. His research thesis focused on alcohol abuse issues. He graduated from the School of Public Health in 1987 with a Masters of Public Health (MPH) degree.
After graduate school, Dr. Jain completed a postdoctoral fellowship in Research Psychiatry with the Gerontology Center of the University of Texas Mental Sciences Institute in Houston. He received the National Research Service Award for the support of the postdoctoral fellowship. After this, he served a three-year residency in Psychiatry at the Department of Psychiatry and Behavioral Sciences at the University of Texas Medical School at Houston as well as a two-year fellowship in Child and Adolescent Psychiatry.
Dr. Jain is currently involved in multiple research projects studying the effects of medications on short-term and long-term treatment of depression, anxiety, pain/mood overlap disorders, and psychosis in adult and child/adolescent populations. He is the author of several articles on the issue of mood and pain conditions. He serves on several Boards focusing on drug development and disease state education. He was recently named "Public Citizen of the Year" by the National Association of Social Workers, Gulf Coast Chapter, in recognition of community and peer education and championing of mental health issues. He was also recently awarded the "Extra Mile Award" by the local school district, in recognition of the service to the children of the school district and consultation to the teachers and counselors. In 2008, at the U.S. Psychiatric Congress, held in San Diego, California, he was the recipient of "Teacher of the Year Award."Larry Culpepper, MD, MPH
Larry Culpepper, MD, MPH, is Professor of Family Medicine and the founding Chairman of the Department of Family Medicine at Boston University School of Medicine. Dr. Culpepper also is Chief of Family Practice at Boston Medical Center. He received his MD degree from Baylor College of Medicine and his MPH degree from Boston University.
An active researcher, Dr. Culpepper has conducted federally funded studies of depression and anxiety, otitis media, and school-based and community interventions to improve pregnancy outcomes and to prevent teen pregnancies. Recently, he served as the principal investigator of an AHRQ funded developmental center for patient safety research devoted to the study of problems affecting low income and minority vulnerable populations in ambulatory care settings, and is a co-investigator of the Primary Care Anxiety Project, a study of the course of anxiety disorders in primary care settings. Dr. Culpepper’s department operates a large hospitalist inpatient service, obstetric and newborn service, and provides leadership to a network of 15 community health centers involving over one million visits annually. It also is responsible for Boston University’s Student Health Service and for the Boston University Medical Center’s Occupational Health Service.
He has served as President of the North American Primary Care Research Group (NAPCRG), and Chairman of the Research Committee of the Society of Teachers of Family Medicine (STFM). Dr. Culpepper is a Primary Care Fellow of the federal Health Resources and Services Administration, and has chaired or served as a member of research grant review committees for five NIH and other federal agencies, and has served on six federal expert panels for consensus committees or evidence-based centers. He founded and is the Chairman of the Board of the Rhode Island Public Health Foundation. He is a member of The Depression and Bipolar Support Alliance and the Anxiety Disorders Association of America Scientific Advisory Boards. He is the editor of the Primary Care Companion to the Journal of Clinical Psychiatry. In 1997 he received the NAPCRG-STFM Career Research Award, and in 1998 was elected to the Institute of Medicine.Disclosure Declaration
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all its CE activities. Faculty must disclose to the participants any significant relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Jain has disclosed that he receives research support from Abbott Laboratories, Addrenex Pharmaceuticals, Inc., Aspect Medical Systems, Inc., Forest Laboratories, Inc., Eli Lilly and Company, and Pfizer Inc. He is on the speakers bureaus of Cyberonics, Inc., GlaxoSmithKline, Jazz Pharmaceuticals, Eli Lilly and Company, Pfizer Inc., Shire Pharmaceuticals, and Takeda Pharmaceuticals North America, Inc. Dr. Jain serves as a consultant to Addrenex Pharmaceuticals, Inc., IMPAX Laboratories, Inc., Eli Lilly and Company, and Shire Pharmaceuticals.
Dr. Culpepper has disclosed that he is on the speakers bureaus of Forest Laboratories, Inc., Pfizer Inc., and Wyeth Pharmaceuticals. He also serves as a consultant to AstraZeneca Pharmaceuticals LP, Forest Laboratories, Inc., Eli Lilly and Company, Pfizer Inc., Somaxon Pharmaceuticals, Inc., Takeda Pharmaceuticals North America, Inc., and Wyeth Pharmaceuticals.Unlabeled Use Disclosure
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
CME Outfitters, LLC, the faculty, and Wyeth Pharmaceuticals do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.Questions about this activity? Call us at 877.CME.PROS (877.263.7767).
WC-006-022309-07
|
||||
 |
 |
 |
||
   |
||||
         
|
|
|||||||||
|
||||||||||
